Name : Ishika Saluja(22Y/F)

Date : 13 Apr 2025

Test Asked : Festive Healthy Couple Package, Esr

Report Status: Interim Report

PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY : DR.
2K/20 BARIATU HOUSING COLONY 834009
TEST ASKED : FESTIVE HEALTHY COUPLE PACKAGE,ESR

Report Availability Summary

Note: Please refer to the table below for status of your tests.

10 Ready 0 Ready with Cancellation 1 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

ERYTHROCYTE SEDIMENTATION RATE (ESR) Processing

FESTIVE HEALTHY COUPLE PACKAGE Ready

25-OH VITAMIN D (TOTAL) Ready

VITAMIN B-12 Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

ROUTINE URINE ANALYSIS Ready

ELEMENTS 22 (TOXIC AND NUTRIENTS) Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY : DR. 2K/20 BARIATU HOUSING COLONY 834009
TEST ASKED : FESTIVE HEALTHY COUPLE PACKAGE,ESR

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
COMPLETE HEMOGRAM
BASOPHILS - ABSOLUTE COUNT 0.01 X 10³ / µL 0.02 - 0.1
EOSINOPHILS 6.3 % 1-6
EOSINOPHILS - ABSOLUTE COUNT 0.57 X 10³ / µL 0.02 - 0.5
LYMPHOCYTE 15.5 % 20-40
MEAN CORP.HEMO.CONC(MCHC) 30.5 g/dL 31.5-34.5
MEAN PLATELET VOLUME(MPV) 14.2 fL 6.5-12
PLATELET DISTRIBUTION WIDTH(PDW) 19.6 fL 9.6-15.2
PLATELET TO LARGE CELL RATIO(PLCR) 58.4 % 19.7-42.4
RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.3 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 52.6 fL 39.0-46.0
LIPID
LDL / HDL RATIO 1.2 Ratio 1.5-3.5
TC/ HDL CHOLESTEROL RATIO 2.5 Ratio 3-5
TOXIC ELEMENTS
BERYLLIUM 0.03 µg/L 0.10 - 0.80
URINOGRAM
URINE BLOOD PRESENT - Absent
VITAMIN
25-OH VITAMIN D (TOTAL) 22.59 ng/mL 30-100

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY 2K/20 BARIATU HOUSING COLONY 834009
: DR.
TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ARSENIC ICP-MS 0.46 µg/L <5
CADMIUM ICP-MS 0.41 µg/L < 1.5
MERCURY ICP-MS 1.22 µg/L <5
LEAD ICP-MS 15.17 µg/L < 150
CHROMIUM ICP-MS 0.93 µg/L < 30
BARIUM ICP-MS 2.1 µg/L < 30
COBALT ICP-MS 0.52 µg/L 0.10 - 1.50
CAESIUM ICP-MS 2.43 µg/L <5
THALLIUM ICP-MS 0.04 µg/L <1
URANIUM ICP-MS 0.02 µg/L <1
STRONTIUM ICP-MS 14.59 µg/L 8 - 38
ANTIMONY ICP-MS 9.02 µg/L 0.10 - 18
TIN ICP-MS 0.78 µg/L <2
MOLYBDENUM ICP-MS 1.72 µg/L 0.70 - 4.0
SILVER ICP-MS 0.56 µg/L <4
VANADIUM ICP-MS 0.29 µg/L < 0.8
BERYLLIUM ICP-MS 0.03 µg/L 0.10 - 0.80
BISMUTH ICP-MS 0.21 µg/L 0.10 - 0.80
SELENIUM ICP-MS 165.8 µg/L 60 - 340
ALUMINIUM ICP-MS 20.8 µg/L < 30
NICKEL ICP-MS 2.59 µg/L < 15
MANGANESE ICP-MS 14.7 µg/L 7.10 - 20
Please correlate with clinical conditions.

Method :
ICP - MASS SPECTROMETRY
Note:Reference range has been obtained after considering 95% population as cutoff.

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 14 Apr 2025 04:32
Report Released on (RRT) : 14 Apr 2025 06:27
Sample Type : EDTA Whole Blood
Labcode : 1304044609/PP004 Dr Saakshi Mittal MD(Path)

Barcode : DS234797 Page : 1 of 12

Scan QR code to verify authenticity of reported results; active for 30 days from release time.
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY 2K/20 BARIATU HOUSING COLONY 834009
: DR.
TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 4.8 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 91 mg/dL

Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 14 Apr 2025 04:32

Report Released on (RRT) : 14 Apr 2025 06:27
Sample Type : EDTA Whole Blood
Labcode : 1304044609/PP004 Dr Saakshi Mittal MD(Path)
Barcode : DS234797
Page : 2 of 12
PROCESSED AT :
Thyrocare,
Plot No.428,Phase-IV,
Udyog Vihar,
Gurgaon,Haryana - 122 015

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY : DR. 2K/20 BARIATU HOUSING COLONY 834009

TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 12.1 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 39.7 % 36.0-46.0
Total RBC HF & EI 4.24 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 93.6 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 28.5 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 30.5 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 52.6 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 15.3 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 337.8 - *Refer Note below
MENTZER INDEX Calculated 22.1 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 9.03 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 74.9 % 40-80
Lymphocytes Percentage Flow Cytometry 15.5 % 20-40
Monocytes Percentage Flow Cytometry 2.9 % 2-10
Eosinophils Percentage Flow Cytometry 6.3 % 1-6
Basophils Percentage Flow Cytometry 0.1 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 6.76 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 1.4 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.26 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.01 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.57 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.03 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 179 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 14.2 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 19.6 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 58.4 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.25 % 0.19-0.39
Remarks : Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 14 Apr 2025 04:32

Report Released on (RRT) : 14 Apr 2025 06:27

Sample Type : EDTA Whole Blood
Labcode : 1304044609/PP004 Dr Saakshi Mittal MD(Path)
Barcode : DS234797 Page : 3 of 12
PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY : DR. 2K/20 BARIATU HOUSING COLONY 834009

TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) C.L.I.A 22.59 ng/mL
Bio. Ref. Interval. :-

DEFICIENCY : <20 ng/ml || INSUFFICIENCY : 20-<30 ng/ml

SUFFICIENCY : 30-100 ng/ml || TOXICITY : >100 ng/ml

Clinical Significance:

Vitamin D is a fat-soluble vitamin that has been known to help the body absorb and retain calcium and phosphorus; both are
critical for building bone health. Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency,
nephrotic syndrome. Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):5.3%, Inter assay (%CV):11.9% ; Sensitivity:3.2 ng/ml.

Kit Validation Reference: Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.

Please correlate with clinical conditions.

Method:- Fully Automated Chemi Luminescent Immuno Assay

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 15:39
Report Released on (RRT) : 13 Apr 2025 17:12
Sample Type : SERUM
Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)
Labcode : 1304090342/PP004
Barcode : DR321698 Page : 4 of 12
PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY : DR. 2K/20 BARIATU HOUSING COLONY 834009

TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS

VITAMIN B-12 C.L.I.A 561 pg/mL
Bio. Ref. Interval. :-

Normal : 211 - 911 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat,
eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin
sheath. Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic
anemias. For diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical
examination and other findings.

Specifications: Intra assay (%CV):5.0%, Inter assay (%CV):9.2 %;Sensitivity:45 pg/ml

Kit Validation reference:

Chen IW, Sperling MI, Heminger LA. Vitamin B12. In: Pesce AJ, Kaplan LA, eds. Methods in Clinical Chemistry. St. Louis: CV Mosby;
1987:569–73.

Please correlate with clinical conditions.

Method:- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 15:39
Report Released on (RRT) : 13 Apr 2025 17:12
Sample Type : SERUM
Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)
Labcode : 1304090342/PP004
Barcode : DR321698 Page : 5 of 12
PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY 2K/20 BARIATU HOUSING COLONY 834009
: DR.
TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 139 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 55 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 66.7 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 115 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 2.5 Ratio 3-5
TRIG / HDL RATIO CALCULATED 2.1 Ratio < 3.12
LDL / HDL RATIO CALCULATED 1.2 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.83 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 84.02 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 23.08 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 15:39
Report Released on (RRT) : 13 Apr 2025 17:12
Sample Type : SERUM
Labcode : 1304090342/PP004 Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)

Barcode : DR321698 Page : 6 of 12

PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY 2K/20 BARIATU HOUSING COLONY 834009
: DR.
TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 68.4 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.51 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.4 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 10.5 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 15.7 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 11.9 U/L < 34
SGOT / SGPT RATIO CALCULATED 1.32 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 6.74 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 3.89 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.85 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.36 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 15:39
Report Released on (RRT) : 13 Apr 2025 17:12
Sample Type : SERUM
Labcode : 1304090342/PP004 Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)

Barcode : DR321698 Page : 7 of 12

PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY 2K/20 BARIATU HOUSING COLONY 834009
: DR.
TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 13.3 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.69 mg/dL 0.55-1.02
BUN / Sr.CREATININE RATIO CALCULATED 19.27 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 28.46 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 41.25 Ratio < 52
CALCIUM PHOTOMETRY 9.2 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4 mg/dL 3.2 - 6.1
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 15:39
Report Released on (RRT) : 13 Apr 2025 17:12
Sample Type : SERUM
Labcode : 1304090342/PP004 Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)

Barcode : DR321698 Page : 8 of 12

 PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

2K/20 BARIATU HOUSING COLONY 834009
REF. BY : DR.

TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) C.M.I.A 84 ng/dL 58-159
TOTAL THYROXINE (T4) C.M.I.A 7.53 µg/dL 4.87-11.72
TSH - ULTRASENSITIVE C.M.I.A 3.442 µIU/mL 0.35-4.94

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4,USTSH - Fully Automated Chemi Luminescent Microparticle Immunoassay

Pregnancy reference ranges for TSH/USTSH :

Trimester || T3 (ng/dl) || T4 (µg/dl) || TSH/USTSH (µIU/ml)
1st || 83.9-196.6 || 4.4-11.5 || 0.1-2.5
2nd || 86.1-217.4 || 4.9-12.2 || 0.2-3.0
3rd || 79.9-186 || 5.1-13.2 || 0.3-3.5
References :
1. Carol Devilia, C I Parhon. First Trimester Pregnancy ranges for Serum TSH and Thyroid Tumor reclassified as
Benign. Acta Endocrinol. 2016; 12(2) : 242 - 243
2. Kulhari K, Negi R, Kalra DK et al. Establishing Trimester specific Reference ranges for thyroid hormones in Indian
women with normal pregnancy : New light through old window. Indian Journal of Contemporary medical research.
2019; 6(4)

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 15:39
Report Released on (RRT) : 13 Apr 2025 17:12
Sample Type : SERUM
Labcode : 1304090342/PP004 Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)
Barcode : DR321698 Page : 9 of 12
PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

REF. BY : DR. 2K/20 BARIATU HOUSING COLONY 834009

TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 126 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- 2021 CKD EPI Creatinine Equation

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 15:39
Report Released on (RRT) : 13 Apr 2025 17:12
Sample Type : SERUM
Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)
Labcode : 1304090342/PP004
Barcode : DR321698 Page : 10 of 12
PROCESSED AT :
Thyrocare
2nd Floor, Saluja Tower,
Plot No.1789, PP compound,
Main Road, Ranchi-834001

NAME : ISHIKA SALUJA(22Y/F) HOME COLLECTION :

2K/20 BARIATU HOUSING COLONY 834009
REF. BY : DR.
TEST ASKED : ESR,FESTIVE HEALTHY COUPLE PACKAGE

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

Complete Urinogram
Physical Examination
VOLUME Visual Determination >=5 mL -
COLOUR Visual Determination PALE YELLOW - Pale Yellow
APPEARANCE Visual Determination CLEAR - Clear
SPECIFIC GRAVITY pKa change > 1.030 - 1.003-1.030
PH pH indicator 5 - 5-8
Chemical Examination
URINARY PROTEIN PEI ABSENT mg/dL Absent
URINARY GLUCOSE GOD-POD ABSENT mg/dL Absent
URINE KETONE Nitroprusside ABSENT mg/dL Absent
URINARY BILIRUBIN Diazo coupling ABSENT mg/dL Absent
UROBILINOGEN Diazo coupling Normal mg/dL <=0.2
URINE BLOOD Peroxidase reaction PRESENT - Absent
NITRITE Diazo coupling ABSENT - Absent
LEUCOCYTE ESTERASE Esterase reaction ABSENT - Absent
Microscopic Examination
URINARY LEUCOCYTES (PUS CELLS) Microscopy ABSENT cells/HPF 0-5

(Reference : *PEI - Protein error of indicator, *GOD-POD - Glucose oxidase-peroxidase)

~~ End of report ~~

Sample Collected on (SCT) : 13 Apr 2025 12:23

Sample Received on (SRT) : 13 Apr 2025 16:22
Report Released on (RRT) : 13 Apr 2025 20:07
Sample Type : URINE
Dr Anupama Sinha MD(Path) Dr.Amit Anand DCP(Path)
Labcode : 1304042643/PP004
Barcode : DR443318 Page : 11 of 12
Scan QR code to verify authenticity of reported results; active for 30 days from release time.
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at [email protected]
or call us on 022-3090 0000

+ T&C Apply, #As on 5th December 2024, *As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 12 of 12